Company intelligence / Profile preview

ChemPacific

Baltimore, Maryland, United Stateschempacific.com ↗

Ownership: Private
Development stage: Commercial

Overview

ChemPacific provides custom synthesis and cGMP manufacturing of high-purity small molecules, intermediates, and APIs for pharmaceutical and biotech clients. The company does not have its own clinical pipeline but supports client programs from early development to commercial scale.

Modalities: Small moleculeBulk chemical (as a manufacturing category)Intermediate (as a manufacturing category)API (Active Pharmaceutical Ingredient)
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

pentostatin

Commercial

Indications: Cancer

Partnerships

Not publicly disclosed; works with major industry leaders in pharma/biotech as contract clients.

Beyond the preview

Go deeper on ChemPacific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemPacific.

Explore the full profile